Keros Therapeutics, Inc. (KROS) NASDAQ

21.36

-0.02(-0.09%)

Updated at December 24 01:00PM

Currency In USD

Valuation

Market Cap592.64M
Enterprise Value51.57M
P/E Ratio13.39
PEG Ratio0.03
Price/Sales Ratio3.49
Price/Book Ratio1.23
Enterprise/Revenue0.75
Enterprise/EBITDA2.46

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.26
Operating Margin0.18

Management Effectiveness

Return On Assets0.09
Return On Equity0.1

Income Statement

Revenue3.55M
Revenue/Share6.07
Gross Profit3.55M
EBITDA-185.82M
Net Income-187.35M
Diluted EPS-5

Balance Sheet

Total Cash693.47M
Total Cash/Share17.07
Total Debt17.43M
Total Debt/Equity0.02
Current Ratio29.86
Book Value Per Share17.32

Price History

52-Week Change27.17
52-Week High22.55
52-Week Low9.12
Moving Average 50 Days17.55
Moving Average 200 Days14.85

Statistics

Average Volume1.04M
Shares Outstanding40.54M
% Held by Institutions86.92

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A